Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome
NCT02100371
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Basal Cell Nevus Syndrome
Interventions
DRUG:
BMS-833923
Sponsor
University Health Network, Toronto